These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23526408)

  • 21. Adult Glioblastoma.
    Alexander BM; Cloughesy TF
    J Clin Oncol; 2017 Jul; 35(21):2402-2409. PubMed ID: 28640706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.
    Butowski N; Chang SM; Lamborn KR; Polley MY; Pieper R; Costello JF; Vandenberg S; Parvataneni R; Nicole A; Sneed PK; Clarke J; Hsieh E; Costa BM; Reis RM; Hristova-Kazmierski M; Nicol SJ; Thornton DE; Prados MD
    Neuro Oncol; 2011 Dec; 13(12):1331-8. PubMed ID: 21896554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide.
    Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Ciner F; Mertsoylu H; Tufan K
    J Neurooncol; 2018 Sep; 139(2):411-419. PubMed ID: 29696530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma.
    Kim N; Chang JS; Wee CW; Kim IA; Chang JH; Lee HS; Kim SH; Kang SG; Kim EH; Yoon HI; Kim JW; Hong CK; Cho J; Kim E; Kim TM; Kim YJ; Park CK; Kim JW; Kim CY; Choi SH; Kim JH; Park SH; Choe G; Lee ST; Kim IH; Suh CO
    Strahlenther Onkol; 2020 Jan; 196(1):58-69. PubMed ID: 31489457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy.
    Ellingson BM; Cloughesy TF; Lai A; Nghiemphu PL; Liau LM; Pope WB
    Neuro Oncol; 2013 Mar; 15(3):382-90. PubMed ID: 23275575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent and ongoing clinical trials in glioblastoma.
    Lombardi G
    Clin Adv Hematol Oncol; 2018 Jul; 16(7):480-483. PubMed ID: 30067618
    [No Abstract]   [Full Text] [Related]  

  • 27. Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?
    Van Gool S; De Vleeschouwer S
    Expert Rev Neurother; 2012 Oct; 12(10):1173-6. PubMed ID: 23082731
    [No Abstract]   [Full Text] [Related]  

  • 28. [Glioblastoma multiforme].
    Nagashima T
    Ryoikibetsu Shokogun Shirizu; 2000; (28 Pt 3):20-2. PubMed ID: 11043168
    [No Abstract]   [Full Text] [Related]  

  • 29. Fractionated Radiation for Newly Diagnosed Supratentorial Glioblastoma Multiforme: In Regard to Brachman et al.
    Brown M; Bernhard E; Mitchel J; Stone H
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):210-211. PubMed ID: 26700716
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence.
    Han SJ; Englot DJ; Birk H; Molinaro AM; Chang SM; Clarke JL; Prados MD; Taylor JW; Berger MS; Butowski NA
    Neurosurgery; 2015 Aug; 62 Suppl 1(Suppl 1):160-5. PubMed ID: 26181937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review.
    Su J; Cai M; Li W; Hou B; He H; Ling C; Huang T; Liu H; Guo Y
    Oncol Res; 2016; 24(2):117-28. PubMed ID: 27296952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing MGMT methylation status and its current impact on treatment in glioblastoma.
    Berghoff AS; Hainfellner JA; Marosi C; Preusser M
    CNS Oncol; 2015; 4(1):47-52. PubMed ID: 25586425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients.
    Evans SM; Putt M; Yang XY; Lustig RA; Martinez-Lage M; Williams D; Desai A; Wolf R; Brem S; Koch CJ
    J Neurooncol; 2016 Apr; 127(2):391-400. PubMed ID: 26746692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing an Algorithm for Optimizing Care of Elderly Patients With Glioblastoma.
    Flanigan PM; Jahangiri A; Kuang R; Truong A; Choi S; Chou A; Molinaro AM; McDermott MW; Berger MS; Aghi MK
    Neurosurgery; 2018 Jan; 82(1):64-75. PubMed ID: 28475720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotherapy with and without temozolomide in elderly patients with glioblastoma.
    Niyazi M; Schwarz SB; Suchorska B; Belka C
    Strahlenther Onkol; 2012 Feb; 188(2):154-9. PubMed ID: 22231634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review of multifocal and multicentric glioblastoma.
    Li Y; Zhang ZX; Huang GH; Xiang Y; Yang L; Pei YC; Yang W; Lv SQ
    J Clin Neurosci; 2021 Jan; 83():71-76. PubMed ID: 33358091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuro-oncology: treatment decisions in elderly patients with glioblastoma.
    Brandes AA; Bartolotti M
    Nat Rev Neurol; 2012 Dec; 8(12):664-5. PubMed ID: 23147854
    [No Abstract]   [Full Text] [Related]  

  • 38. First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
    Liau LM; Ashkan K; Tran DD; Campian JL; Trusheim JE; Cobbs CS; Heth JA; Salacz M; Taylor S; D'Andre SD; Iwamoto FM; Dropcho EJ; Moshel YA; Walter KA; Pillainayagam CP; Aiken R; Chaudhary R; Goldlust SA; Bota DA; Duic P; Grewal J; Elinzano H; Toms SA; Lillehei KO; Mikkelsen T; Walbert T; Abram SR; Brenner AJ; Brem S; Ewend MG; Khagi S; Portnow J; Kim LJ; Loudon WG; Thompson RC; Avigan DE; Fink KL; Geoffroy FJ; Lindhorst S; Lutzky J; Sloan AE; Schackert G; Krex D; Meisel HJ; Wu J; Davis RP; Duma C; Etame AB; Mathieu D; Kesari S; Piccioni D; Westphal M; Baskin DS; New PZ; Lacroix M; May SA; Pluard TJ; Tse V; Green RM; Villano JL; Pearlman M; Petrecca K; Schulder M; Taylor LP; Maida AE; Prins RM; Cloughesy TF; Mulholland P; Bosch ML
    J Transl Med; 2018 May; 16(1):142. PubMed ID: 29843811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risks.
    Sarkaria JN; Galanis E; Wu W; Dietz AB; Kaufmann TJ; Gustafson MP; Brown PD; Uhm JH; Rao RD; Doyle L; Giannini C; Jaeckle KA; Buckner JC
    Clin Cancer Res; 2010 Nov; 16(22):5573-80. PubMed ID: 20921209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating progression-free survival in patients with glioblastoma using routinely collected data.
    Kelly C; Majewska P; Ioannidis S; Raza MH; Williams M
    J Neurooncol; 2017 Dec; 135(3):621-627. PubMed ID: 28956223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.